UBE2O
Basic information
Region (hg38): 17:76389456-76453152
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the UBE2O gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 50 | 50 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 50 | 0 | 1 |
Variants in UBE2O
This is a list of pathogenic ClinVar variants found in the UBE2O region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-76391001-G-A | not specified | Uncertain significance (May 10, 2022) | ||
17-76391013-C-T | not specified | Uncertain significance (Dec 26, 2023) | ||
17-76391142-G-A | not specified | Uncertain significance (May 03, 2024) | ||
17-76391151-G-A | not specified | Uncertain significance (Dec 19, 2022) | ||
17-76391202-C-T | not specified | Uncertain significance (Dec 13, 2022) | ||
17-76391280-C-A | not specified | Uncertain significance (Dec 04, 2024) | ||
17-76391284-A-G | not specified | Uncertain significance (Jul 17, 2024) | ||
17-76391292-A-G | not specified | Uncertain significance (Jun 07, 2023) | ||
17-76391314-C-T | not specified | Uncertain significance (Oct 29, 2024) | ||
17-76391319-G-A | not specified | Uncertain significance (May 26, 2023) | ||
17-76391328-G-A | not specified | Uncertain significance (Jun 29, 2023) | ||
17-76391343-T-C | not specified | Uncertain significance (Nov 21, 2024) | ||
17-76391401-G-A | not specified | Uncertain significance (Sep 14, 2023) | ||
17-76391404-T-C | not specified | Uncertain significance (Nov 21, 2022) | ||
17-76391413-G-A | not specified | Uncertain significance (Nov 10, 2022) | ||
17-76391461-C-T | not specified | Uncertain significance (Sep 30, 2022) | ||
17-76396260-C-T | not specified | Uncertain significance (Oct 08, 2024) | ||
17-76396284-C-T | not specified | Uncertain significance (Jul 12, 2022) | ||
17-76396287-C-T | not specified | Uncertain significance (Dec 21, 2023) | ||
17-76396413-C-T | not specified | Uncertain significance (May 01, 2024) | ||
17-76396449-C-T | not specified | Uncertain significance (Aug 14, 2024) | ||
17-76396481-T-C | not specified | Uncertain significance (May 24, 2023) | ||
17-76396532-G-C | not specified | Uncertain significance (Oct 25, 2024) | ||
17-76396548-C-T | not specified | Uncertain significance (May 21, 2024) | ||
17-76396553-A-G | not specified | Uncertain significance (Sep 29, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
UBE2O | protein_coding | protein_coding | ENST00000319380 | 18 | 63757 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 2.65e-7 | 125742 | 0 | 6 | 125748 | 0.0000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.44 | 482 | 747 | 0.645 | 0.0000466 | 8439 |
Missense in Polyphen | 149 | 302.77 | 0.49212 | 3296 | ||
Synonymous | 0.597 | 304 | 318 | 0.957 | 0.0000223 | 2576 |
Loss of Function | 6.51 | 3 | 55.3 | 0.0543 | 0.00000301 | 627 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000578 | 0.0000578 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000353 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: E2/E3 hybrid ubiquitin-protein ligase that displays both E2 and E3 ligase activities and mediates monoubiquitination of target proteins (PubMed:23455153, PubMed:24703950). Negatively regulates TRAF6-mediated NF-kappa-B activation independently of its E2 activity (PubMed:23381138). Acts as a positive regulator of BMP7 signaling by mediating monoubiquitination of SMAD6, thereby regulating adipogenesis (PubMed:23455153). Mediates monoubiquitination at different sites of the nuclear localization signal (NLS) of BAP1, leading to cytoplasmic retention of BAP1. Also able to monoubiquitinate the NLS of other chromatin- associated proteins, such as INO80 and CXXC1, affecting their subcellular location (PubMed:24703950). Acts as a regulator of retrograde transport by assisting the TRIM27:MAGEL2 E3 ubiquitin ligase complex to mediate 'Lys-63'-linked ubiquitination of WASHC1, leading to promote endosomal F-actin assembly (PubMed:23452853). {ECO:0000269|PubMed:23381138, ECO:0000269|PubMed:23452853, ECO:0000269|PubMed:23455153, ECO:0000269|PubMed:24703950}.;
- Pathway
- Ubiquitin mediated proteolysis - Homo sapiens (human);protein ubiquitylation;Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
(Consensus)
Recessive Scores
- pRec
- 0.110
Intolerance Scores
- loftool
- 0.163
- rvis_EVS
- -0.81
- rvis_percentile_EVS
- 12.05
Haploinsufficiency Scores
- pHI
- 0.536
- hipred
- Y
- hipred_score
- 0.825
- ghis
- 0.553
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.871
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ube2o
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); cellular phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); neoplasm;
Gene ontology
- Biological process
- protein monoubiquitination;positive regulation of BMP signaling pathway;retrograde transport, endosome to Golgi;protein K63-linked ubiquitination
- Cellular component
- nucleus;cytoplasm;cytosol;nuclear body
- Molecular function
- RNA binding;ubiquitin-protein transferase activity;protein binding;ATP binding;ubiquitin protein ligase activity;ubiquitin conjugating enzyme activity